Printable version
Negative Clinical News has a Significant Impact on Formulary Access (PDF 245KB)
Archives
April 2008: Collateral Formulary Access Impact in the Sleep Disorder Class due to Patent Loss for Ambien
December 2007: Lack of Impact from Two Key Generics in the Anti-depressant Formulary Market
October 2007: Formulary Position Differences between Commercial and Medicare Plans
Welcome!
Fingertip Formulary Insights™ is a series of ongoing reports that analyze various important aspects of the managed care marketplace. As always, we welcome your feedback. We hope you find this report informative and we welcome your suggestions for future topics.
This month's featured article: Negative Clinical News has a Significant Impact on Formulary Access
Executive Summary
In this issue of Fingertip Formulary INSIGHTS™, we analyze the impact of negative clinical news on two drugs that have been in the media for the past few years: Vytorin and Avandia. In each case, negative news (which includes FDA alerts, medical journal articles, and general news media coverage) appears to have contributed to the decline in formulary access. Our objective was to determine if there was a correlation between the release of negative news and changes in formulary access for these drugs.